InspireMD to Report First Quarter 2020 Financial Results and Provide Business Update on Tuesday, May 12
Management to host conference call and webcast at 8:30am EDT
TEL AVIV, Israel, May 05, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today that management will host a conference call and webcast on Tuesday, May 12, 2020, to discuss financial results for the first quarter ended March 31, 2020, and provide a corporate update.
|Conference Call & Webcast:|
|Tuesday, May 12th @ 8:30am EDT|
|Within the US:||877-451-6152|
|Outside the US:||201-389-0879|
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for treatment of carotid artery disease by providing outstanding acute results and durable stroke free long-term outcomes.
InspireMD’s common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbols NSPR.WS and NSPR.WSB.
Chief Financial Officer
LifeSci Advisors, LLC